From Candidate To Clinic: Strategies To Select, Assess, Formulate, And Deliver The Right Drug Candidate In The Early Phase
There are several strategies that a company can take to optimize resources and improve success in the early phase. By harnessing data to drive development decisions, companies can shorten timelines, improve clinical outcomes, and reduce costs in the long-term. Identifying issues early can result in fewer problems down the line and greater confidence in development decisions. This webcast focuses on a number of key considerations for transitioning a molecule from discovery to Phase 1.